Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(2;4)(p22;q12) STRN/PDGFRA

Written2008-05Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers; CHU Poitiers Hospital, F-86021 Poitiers, France

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS
ICD-Morpho 9965/3 Myeloid and lymphoid neoplasms with PDGFRA rearrangement
ICD-Morpho 9975/3 Chronic myelogenous leukaemia, BCR-ABL1 positive; Myeloproliferative neoplasm, unclassifiable; Myelodysplastic/myeloproliferative neoplasm, unclassifiable
Atlas_Id 2136

Clinics and Pathology

Disease Myeloproliferative disease with eosinophilia
Epidemiology Only one case to date, a 64 year old male patient.
Prognosis The patient remained in complete remission for 24 months of treatment with imatinib, but refused any more treatment, althoughthere was no side effect. Elevated eosinophil counts were again detected 14 months after end of treatment.

Genes involved and Proteins

Gene NameSTRN (striatin, calmodulin binding protein)
Location 2p22.2
Protein Composed of a caveolin-binding domain, a coiled-coil domain, a calmodulin-binding domain, and at least 6 WD-repeats. Striatin (STRN) binds many proteins, and forms multi-protein complexes. It is a scaffolding protein; striatin contains a caveolin-binding consensus motif, and binds caveolin-1, the major protein involved in caveolae and lipid rafts. Striatin is also involved in signaling and trafficking in a Ca2+ dependant manner, exhibiting a dual role in endocytic process and signaling.
Gene NamePDGFRA (platelet-derived growth factor receptor, alpha polypeptide)
Location 4q12
Protein Composed of an extracellular domain (the immunoglobulin-like motifs), a transmembrane domain, with an inhibitory juxtamembrane WW-like domain (Irusta et al., 2002), and an intracellular domain (kinase domain) Receptor tyrosine kinase; forms homodimer, and heterodimer with PDGFRB; dimerization induces kinase domain activation, leading to the activation of intracellular signalling pathways (Kawagishi et al., 1995).
Somatic mutations Hybrid genes between various partners and PDFRGA occur in chronic myeloid leukaemia-like diseases with eosinophilia, mostly chronic eosinophilic leukemia (CEL), a clonal hypereosinophilic syndrome. PDGFRA partners known so far are: STRN (2p24), herein described (Curtis et al., 2007), FIP1L1 (4q12) (Cools et al., 2003; Pardanani et al., 2004), CDK5RAP2 (9q33) (Walz et al., 2006), KIF5B (10p11) (Score et al., 2006), ETV6 (12p13) (Curtis et al., 2007), and BCR (22q11) (Baxter et al., 2002).
Mutations of platelet-derived growth factor receptor-alpha (PDGFRA) are observed in a subset of gastrointestinal stromal tumors (GISTs) (Heinrich et al., 2003).
Tumours with PDGFRA involvement are responsive to imatinib therapy (Cools et al., 2003; Debiec-Rychter et al., 2004).

Result of the chromosomal anomaly

Hybrid gene
Transcript 5' STRN-3' PDGFRA; Fusion between STRN intron 6 and a truncated PDGFRA exon 12; reciprocal product not found -> in frame fusion between STRN exon 6 and PDGFRA exon 12.
  
Fusion Protein
Description The N-term STRN - C-term PDGFRA fusion protein retains the caveolin-binding domain, the coiled-coil domain, and the calmodulin-binding domain, but not the WD-repeats of STRN, fused to a truncated WW-like domain and the kinase domain of PDGFRA; the coiled-coil domain from STRN may act as a dimerization motif that could constitutively activate PDGFRA tyrosine kinase.
  

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.

Bibliography

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.
Baxter EJ, Hochhaus A, Bolufer P, Reiter A, Fernandez JM, Senent L, Cervera J, Moscardo F, Sanz MA, Cross NC.
Hum Mol Genet. 2002 Jun 1;11(12):1391-7.
PMID 12023981
 
The striatin family: a new signaling platform in dendritic spines.
Benoist M, Gaillard S, Castets F.
J Physiol Paris. 2006 Mar-May;99(2-3):146-53. Epub 2006 Feb 7. (Review)
PMID 16460920
 
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG.
N Engl J Med. 2003 Mar 27;348(13):1201-14.
PMID 12660384
 
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins.
Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP.
J Biol Chem. 1997 Mar 7;272(10):6525-33.
PMID 9045678
 
Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.
Curtis CE, Grand FH, Musto P, Clark A, Murphy J, Perla G, Minervini MM, Stewart J, Reiter A, Cross NC.
Br J Haematol. 2007 Jul;138(1):77-81.
PMID 17555450
 
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.
Debiec-Rychter M, Dumez H, Judson I, Wasag B, Verweij J, Brown M, Dimitrijevic S, Sciot R, Stul M, Vranck H, Scurr M, Hagemeijer A, van Glabbeke M, van Oosterom AT; EORTC Soft Tissue and Bone Sarcoma Group.
Eur J Cancer. 2004 Mar;40(5):689-95.
PMID 15010069
 
Striatin, a calmodulin-dependent scaffolding protein, directly binds caveolin-1.
Gaillard S, Bartoli M, Castets F, Monneron A.
FEBS Lett. 2001 Nov 9;508(1):49-52.
PMID 11707266
 
PDGFRA activating mutations in gastrointestinal stromal tumors.
Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA.
Science. 2003 Jan 31;299(5607):708-10.
PMID 12522257
 
Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor.
Irusta PM, Luo Y, Bakht O, Lai CC, Smith SO, DiMaio D.
J Biol Chem. 2002 Oct 11;277(41):38627-34. Epub 2002 Aug 13.
PMID 12181311
 
Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.
Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T.
Genomics. 1995 Nov 20;30(2):224-32.
PMID 8586421
 
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.
Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL, Ho CL, Li CY, Dewald GW, Tefferi A.
Blood. 2004 Nov 15;104(10):3038-45.
PMID 15284118
 
Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia.
Score J, Curtis C, Waghorn K, Stalder M, Jotterand M, Grand FH, Cross NC.
Leukemia. 2006 May;20(5):827-32.
PMID 16498388
 
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.
Walz C, Curtis C, Schnittger S, Schultheis B, Metzgeroth G, Schoch C, Lengfelder E, Erben P, Muller MC, Haferlach T, Hochhaus A, Hehlmann R, Cross NC, Reiter A.
Genes Chromosomes Cancer. 2006 Oct;45(10):950-6.
PMID 16845659
 

Citation

This paper should be referenced as such :
Huret, JL
t(2;4)(p22;q12)
Atlas Genet Cytogenet Oncol Haematol. 2009;13(5):381-382.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Anomalies/t0204p22q12ID2136.html


Other genes implicated (Data extracted from papers in the Atlas) [ 2 ]

Genes PDGFRA STRN

Translocations implicated (Data extracted from papers in the Atlas)

 t(2;4)(p22;q12) STRN/PDGFRA

External links

STRN (2p22.2) PDGFRA (4q12)

STRN (2p22.2) PDGFRA (4q12)

Mitelman databaset(2;4)(p22;q12) [Case List]    t(2;4)(p22;q12) [Association List] Mitelman database (CGAP - NCBI)
arrayMapTopo ( C42) Morph ( 9965/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
arrayMapTopo ( C42) Morph ( 9975/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
 
Mitelman databaseSTRN/PDGFRA [MCList]  STRN (2p22.2) PDGFRA (4q12)
TICdbSTRN/PDGFRA  STRN (2p22.2) PDGFRA (4q12)
 
Disease databaset(2;4)(p22;q12) STRN/PDGFRA
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Sep 18 17:19:11 CEST 2017


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.